CN.ORTH: Clinical Hold Lifted in Time for 3Q:22 Results
By John Vandermosten, CFA
CNSX:ORTH.CN | OTC:ORTIF
READ THE FULL ORTH.CN RESEARCH REPORT
XPHYF: 3a Acquisition Expected to Accelerate Growth in Point-of-Care Biosensor Market
By M. Marin
OTC:XPHYF
READ THE FULL XPHYF RESEARCH REPORT
YTRA: Topline Recovery, Omicron Not Too Bad Impact So Far and Additional Listing on India Stock Exchanges Appears Likely
By T. Moore, CFA
NASDAQ:YTRA
READ THE FULL YTRA RESEARCH REPORT
LEXX: An R&D Extravaganza
By John Vandermosten, CFA
NASDAQ:LEXX
READ THE FULL LEXX RESEARCH REPORT
WKSP: Worksport entering a new growth phase in its core business while transforming into a clean energy solutions provider.
By Thomas Kerr, CFA
NASDAQ:WKSP
READ THE FULL WKSP RESEARCH REPORT
TNXP: Infectious Disease Investments Likely to Pay Off…
By David Bautz, PhD
NASDAQ:TNXP
READ THE FULL TNXP RESEARCH REPORT
BCLI: Phase 3 ALS Results Published in Muscle and Nerve…
By David Bautz, PhD
NASDAQ:BCLI
READ THE FULL BCLI RESEARCH REPORT
BIOX: Bioceres Crop Solutions reports 1st quarter of fiscal 2022 financial results and reviews operational accomplishments. Bioceres received regulatory approval in Brazil for HB4 wheat flour for human consumption.
By Steven Ralston, CFA
NASDAQ:BIOX
READ THE FULL BIOX RESEARCH REPORT
BIOX: Bioceres Crop Solutions reports 1st quarter of fiscal 2022 financial results and reviews operational accomplishments. Bioceres received regulatory approval in Brazil for HB4 wheat flour for human consumption.
By Steven Ralston, CFA
NASDAQ:BIOX
READ THE FULL BIOX RESEARCH REPORT
ABVC: Moving Forward on Several 2022 Goals to Advance Growth Strategy
By M. Marin
NASDAQ:ABVC
READ THE FULL RESEARCH REPORT